ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$919.21
Tradestie Score
52
Market Cap
$46.96B
P/E Ratio
35.7
Revenue Growth
0.6%
Analyst Upside
+28.4%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals Inc
|
$504.73
|
$103.64B | 29.7 | 55 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$735.20
|
$63.59B | 18.8 | 48 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$219.72
|
$60.38B | 42.9 | 49 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.07
|
$36.81B | 64.1 | 56 | Compare |
|
INSM
Insmed, Inc.
|
$111.12
|
$31.13B | - | 49 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.90
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.75
|
$19.56B | 27.2 | 47 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.30
|
$16.93B | 15.5 | 56 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.16
|
$15.70B | 31.3 | 70 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.76
|
$15.22B | - | 49 | Compare |
More ARGX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry